Related Experiment Video
Updated: Sep 7, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Drug-induced Liver Injury in Pediatrics
Fernanda Monge-Urrea1, Ericka Montijo-Barrios
1From the Division of Pediatric Gastroenterology and Nutrition, Instituto Nacional de Pediatría, Mexico City, Mexico.
Insights
Drug-induced liver injury (DILI) is a rare cause of pediatric liver disease, often linked to antibiotics and antiepileptics. Prompt drug withdrawal is key for managing DILI in children.
Area of Science:
- Pediatric Hepatology
- Clinical Pharmacology
- Drug Safety and Toxicology
Background:
- Drug-induced liver injury (DILI) is an underdiagnosed cause of liver disease in children, accounting for approximately 10% of all DILI cases.
- The exact incidence of DILI in the pediatric population remains unknown.
- Commonly implicated hepatotoxic medications in children include antibiotics and antiepileptic drugs.
Purpose of the Study:
- To review the characteristics, diagnosis, and management of drug-induced liver injury in pediatric patients.
- To highlight the significance of DILI as a cause of liver disease in children.
- To emphasize the importance of accurate causality assessment and prompt intervention.
Main Methods:
- Review of existing literature and case reports on pediatric DILI.
- Discussion of DILI classification (intrinsic vs. idiosyncratic) and injury patterns (hepatocellular vs. cholestatic).
- Application of the Roussel Uclaf Causality Assessment Method (RUCAM) for diagnosis.
Main Results:
- DILI presents primarily with hepatocellular or cholestatic injury patterns in children.
- Antibiotics and antiepileptics are the most frequent culprits.
- The Roussel Uclaf Causality Assessment Method (RUCAM) aids in diagnosing DILI.
Conclusions:
- Drug-induced liver injury is a critical consideration in pediatric liver disease.
- Early identification and withdrawal of the offending agent are paramount for successful treatment.
- Further research is needed to establish the precise incidence and risk factors for DILI in children.
Abstract:
Drug-induced liver injury (DILI) is a rare, underdiagnosed cause of liver disease in children. The incidence of DILI in the pediatric population is unknown but it represents around 10% of all DILI cases. The most common hepatotoxic drugs in children are antibiotics and antiepileptics. DILI is classified as intrinsic or idiosyncratic and it presents mostly with 2 patterns of injury: hepatocellular or cholestatic. Diagnosis can be done with help of the Roussel Uclaf Causality Assessment Method (RUCAM) casualty assessment. The mainstay of treatment is prompt withdrawal of the suspect drug.
Related Concept Videos
Factors Affecting Drug Response: Overview
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inborn Errors of Metabolism
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Hepatic Drug Excretion: Influencing Factors

